India–Japan Joint Vision for the Next Decade: Strategic Convergence and Regional Integration

The India–Japan Special Strategic and Global Partnership has entered a decisive new chapter. At the 15th Annual Summit in Tokyo on 29 and 30 August 2025, India’s Prime Minister Narendra Modi and Japanese Prime Minister Shigeru Ishiba adopted the Joint Vision for the Next Decade, a whole-of-nation framework organized around eight pillars: economy, economic security, mobility, environment, technology and innovation, health, people-to-people ties, and state-prefecture engagement. [1,2] The vision sets a new private investment target of JPY 10 trillion (approximately USD 63 billion), doubling the previous five-year commitment, and positions AI as a central pillar of the bilateral relationship. [2,3]

For senior leadership across healthcare payor and provider organizations, this partnership is not merely a geopolitical development. It is a structural accelerator for cross-border healthcare technology, workforce mobility, AI governance harmonization, and digital health infrastructure—all areas where both nations bring complementary strengths and face converging challenges. This partnership is strategically transformative, enabling the emergence of a cross-border healthcare operating model that combines Japan’s demand, capital, and governance maturity with India’s scale, workforce, and digital public infrastructure. By aligning AI governance, workforce mobility, and digital health ecosystems, it shifts Asia’s healthcare paradigm from fragmented national systems to integrated, intelligence-driven, and regionally interoperable care delivery models.

The Demographic Imperative: Why Healthcare Is a Defining Arena for This Partnership

The India–Japan partnership is uniquely shaped by a demographic complementarity that creates structural demand for healthcare collaboration:

Japan: The Super-Aged Society Under Fiscal Pressure

• Approximately 30% of Japan’s population is aged 65 or older, making it one of the most aged societies globally. [4,15] By 2042, the absolute number of seniors over 65 is projected to peak as baby-boomer cohorts age further. [18]
• Japan allocates 10.6% of GDP to health spending ($5,790 per capita). [4] Those aged 75 and above now account for over 40% of total medical expenditure for the first time. Elderly medical spending rose from JPY 12.7 trillion in 2010 to JPY 19.6 trillion in 2024. This investment commitment signals a structural shift from bilateral cooperation to sustained, large-scale capital deployment in healthcare infrastructure, AI, and medtech ecosystems across Asia. [5]
• Long-term care workforce shortages are critical, with only 58.4% of certified care workers active in aged care; annual turnover rates remain high at approximately 15%. [18]
• Japan enacted its AI Promotion Act in 2025 and launched a Nationwide Medical Information Platform for electronic health data sharing, scheduled for full-scale operation in FY 2025. [12,15]

India: Digital Health at Scale in a Young, Growing Economy

• India’s digital health market was valued at approximately USD 14.5–17.8 billion in 2024–2025 and is projected to reach about USD 107 billion by 2033, growing at a CAGR of over 25%. [6]
• The Ayushman Bharat Digital Mission (ABDM) has created over 900 million health accounts (ABHA), linked 1 billion health records, and registered more than 520,000 health facilities and over 900,000 healthcare professionals as of mid-2026. [8]
• AI-enabled tools within the National TB Elimination Programme have contributed to a 27% decline in adverse tuberculosis (TB) outcomes, and 282 million telemedicine consultations between April 2023 and November 2025 have served 12 million patients through AI-recommended diagnoses. [7]
• India joined the HealthAI Global Regulatory Network as a founding pioneer country, working through Indian Council of Medical Research -National Institute for Research in Digital Health and Data Science and IndiaAI to contribute to global AI governance in healthcare. [17]

AVASANT PERSPECTIVE

This partnership reflects a broader structural shift toward a cross-border healthcare operating model that integrates Japan’s demand, capital, and governance strengths with India’s scale, workforce, and digital public infrastructure. It signals a transition from parallel national healthcare systems to an interconnected, intelligence-driven regional ecosystem spanning the Indo-Pacific region. Healthcare payors and providers with cross-border exposure should evaluate this partnership as a structural market shaper, not a policy footnote.

AI and Technology as the Structural Backbone of Bilateral Healthcare Convergence

The August 2025 Summit launched the Japan–India AI Cooperation Initiative (JAI), followed by the first AI Strategic Dialogue held in Mumbai on April 21, 2026. [9,10] AI has been formally positioned as a central pillar of the Joint Vision, with concrete collaborative mechanisms now operational.

1. AI Governance Harmonization

• Japan’s AI Promotion Act (2025) and AI Business Operator Guidelines (v1.1, March 2025) emphasize voluntary compliance, transparency, and human-centric development. [12] India’s IndiaAI Mission and participation in the Hiroshima AI Process create a shared governance vocabulary. [14]
• The AI Strategic Dialogue covers the entire AI stack, from cocreation of industrial AI solutions, AI talent mobility, and AI governance alignment, to engagement in multilateral forums. [9,10]
• Both nations are working toward policy convergence to enable seamless cross-border AI innovation, with Japan contributing governance maturity and India contributing scale and digital public infrastructure. [10,14]

2. Digital Partnership 2.0 and Semiconductor Supply Chain

• India and Japan renewed the Memorandum of Cooperation (MoC) on Digital Partnership 2.0 in 2025, covering semiconductors, AI, digital public infrastructure, R&D, and startups. [11]
• The semiconductor supply chain partnership, formalized through a 2023 MoC, has catalyzed investments, including Renesas Electronics’ Outsourced Semiconductor Assembly and Test facility in Gujarat, Tokyo Electron’s partnership with TATA Electronics, and collaborative design centers under the Ministry of Electronics and Information Technology of India’s Chips to Startup program. [11,21]
• Japan is investing over JPY 10 trillion into semiconductors and AI over seven years. Semiconductor infrastructure is foundational to medical devices, AI compute, and healthcare IoT. [20]

3. AI-Driven Healthcare Applications

• Japan has commercialized a federated AI drug discovery model through Elix and the Life Intelligence Consortium (LINC), supported by the Japan Agency for Medical Research and Development. This is the first such platform globally incorporating federated learning across 16 pharmaceutical companies. [12]
• India’s IndiaAI Application Development Initiative has shortlisted multiple healthcare AI solutions, and the National Health Authority has partnered with IIT Kanpur to develop federated learning platforms for clinical AI model validation under ABDM. [7,8]

4. Medtech and Digital Health Device Collaboration

• Over 1,450 Japanese companies now operate in India, with a growing medtech presence. Fujifilm is expanding AI-equipped NURA health screening centers, Omron invested INR 128 crore for its first India facility in Chennai (2025), and Canon is expanding its medical imaging business. [13]
• MediBuddy (India) and Elecom (Japan) have partnered to develop smart health IoT devices for the Indian market. Japan’s Medical and Biological Laboratories has transferred diagnostic protein test technology to India’s Agappe Diagnostics. [13]
• The Asian Development Bank (ADB), ADB Institute, and Japan International Cooperation Agency (JICA) co-organized training workshops on AI applications in healthcare, focusing on data security, workforce readiness, and governance for AI adoption across developing Asia. [16]

The Workforce Corridor: Addressing Japan’s Critical Healthcare Staffing Crisis

The Joint Vision includes an action plan targeting the exchange of more than 500,000 personnel over the next five years, with priority sectors including caregiving, construction, and hospitality. [2,19] For healthcare, this creates a significant bilateral workforce corridor:

• India’s expanding working-age population represents a vast pool of potential nurses and caregivers. The 2018 MoC on Healthcare and Wellness aligned India’s Ayushman Bharat with Japan’s Asia Health and Wellbeing Initiative (AHWIN), mandating Japanese language training centers for Indian caregivers. [3,20]
• The Specified Skilled Worker (SSW) and Technical Intern Training Programme (TITP) pathways are being scaled, with 50,000 skilled workers from India targeted for placement in Japan under these frameworks. [19]
• Digital talent exchanges are focused on software-defined vehicles, AI, and semiconductor design—skills increasingly critical for medtech, health informatics, and clinical decision support. [11,14]
• Japan’s Ministry of Education Culture, Sports, Science and Technology signed a Joint Statement of Interest with India’s Ministry of Science and Technology, supporting Indian postgraduate and doctoral students conducting research in Japan through the LOTUS program and Sakura Science Exchange Program. [1,11]

AVASANT PERSPECTIVE

Healthcare payors and providers in both markets should monitor the bilateral workforce corridor as a structural solution for clinical and technical staffing shortages. Japanese health systems gain access to cost-effective, trained human capital; Indian health systems gain exposure to Japanese quality standards, eldercare models, and advanced medtech practices.

Regional Integration: Indo-Pacific Health Infrastructure and Supply Chain Resilience

The bilateral partnership is embedded within a broader Indo-Pacific architecture that has direct implications for healthcare supply chains, regulatory harmonization, and infrastructure development:

• The alignment of Japan’s Free and Open Indo-Pacific vision with India’s Act East Policy creates a strategic corridor for healthcare technology transfer, medical device supply chains, and pharmaceutical collaboration across Southeast and East Asia. [3]
• The Economic Security Initiative, launched jointly, strengthens supply chain resilience in semiconductors, critical minerals, clean energy, and telecommunications—all foundational to healthcare IT infrastructure and medtech manufacturing. [11,21]
• JICA has committed over JPY 3.7 trillion for infrastructure projects, including metro systems in six Indian cities and the Mumbai–Ahmedabad High-Speed Rail, improving healthcare accessibility and specialist referral networks. [3,20]
• Japan’s Pharmaceutical and Medical Devices Agency (PMDA) regulatory harmonization efforts through ARISE create a pathway for jointly developed medtech products to access broader Asian markets. [22]

Avasant Perspective: Four Imperatives for Healthcare Leadership

The India–Japan Joint Vision for the Next Decade is a structural investment framework, not an aspirational statement. Healthcare payor and provider leadership should focus on four imperatives:

1. Treat the Bilateral Corridor as Healthcare Infrastructure, Not Diplomacy

• The JPY 10 trillion investment commitment, AI cooperation initiative, and workforce exchange programs constitute real infrastructure for healthcare delivery, financing, and technology integration. Organizations that build partnerships along this corridor—in medtech procurement, workforce sourcing, or AI codevelopment—will gain first-mover advantage in the fastest-growing healthcare market in Asia. [6]

2. Invest in AI Governance Alignment as a Market Access Strategy

• Japan’s principles-based AI governance (AI Promotion Act, Hiroshima AI Process) and India’s participation in the HealthAI Global Regulatory Network are converging toward compatible frameworks. Healthcare organizations that align their AI deployment strategies with this bilateral governance architecture will be better positioned for cross-border clinical AI validation, regulatory clearance, and data-sharing partnerships.

3. Leverage the Workforce Corridor for Clinical and Technical Talent

• Japan’s eldercare staffing crisis and India’s demographic dividend create a bilateral workforce pipeline with implications for nursing, caregiving, health informatics, and medtech engineering. Payors and providers should proactively engage with the SSW and TITP frameworks and explore institutional partnerships with Japanese universities and training institutes.

4. Position for the Indo-Pacific Health Technology Value Chain

• The semiconductor supply chain partnership, digital health device collaborations, and PMDA-aligned regulatory harmonization efforts are creating an integrated health technology value chain spanning Japan, India, and Southeast Asia. Organizations that embed themselves in this value chain—through joint R&D, co-manufacturing, or multimarket regulatory strategies—will define the next generation of healthcare delivery in Asia.

Key Indicators at a Glance

The Road Ahead: From Bilateral Vision to Operational Reality

The India–Japan Joint Vision for the Next Decade represents the most comprehensive bilateral framework for technology, economic, and social cooperation between two of Asia’s largest democracies. For healthcare payor and provider leadership, the strategic message is unambiguous:

• The bilateral AI cooperation architecture, workforce exchange pipeline, and semiconductor supply chain partnership are not simply aspirational policy statements; they are operational frameworks with committed capital, institutional mechanisms, and measurable targets.
• The convergence of Japan’s super-aged healthcare challenges with India’s digital health scale creates mutual dependencies that will reshape care delivery models, medical device supply chains, and clinical workforce strategies across the Indo-Pacific.
• Organizations that embed themselves within this bilateral framework—through technology partnerships, workforce programs, or regulatory alignment strategies will be structurally advantaged as both nations execute their healthcare modernization agendas.

The next generation of healthcare leadership in Asia will be defined not by domestic optimization alone but by the ability to operate across the bilateral and regional corridors that the India–Japan Joint Vision is now systematically building.

References

1. Prime Minister of India, “15th India-Japan Annual Summit Joint Statement: Partnership for Security and Prosperity of Our Next Generation,” 29–30 August 2025. https://www.pmindia.gov.in/en/news_updates/15th-india-japan-annual-summit-joint-statement-partnership-for-security-and-prosperity-of-our-next-generation/
2. Government of India, Press Information Bureau, “India–Japan Joint Vision for the Next Decade: Eight Directions to Steer the Special Strategic and Global Partnership,” PIB, 30 August 2025. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2161986
3. Ministry of Foreign Affairs of Japan, “Japan-India Relations (Basic Data),” Updated February 2026. https://www.mofa.go.jp/region/asia-paci/india/data.html
4. OECD, “Health at a Glance 2025: Japan Country Note,” OECD Health Statistics, November 2025. https://www.oecd.org/en/publications/health-at-a-glance-2025_15a55280-en/japan_319bfc39-en.html
5. P4H Network, “Japan’s Aging Crisis Pushes Health Insurance Premiums to Record Highs,” October 2025. https://p4h.world/en/news/japans-aging-crisis-pushes-health-insurance-premiums-to-record-highs/
6. Grand View Research, “India Digital Health Market Size, Share | Industry Report 2033,” 2025. https://www.grandviewresearch.com/industry-analysis/india-digital-health-market-report
7. Government of India, Press Information Bureau, “Transforming Healthcare Delivery Through Artificial Intelligence,” February 2026. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2026/feb/doc2026213788701.pdf
8. Ayushman Bharat Digital Mission (ABDM), https://abdm.gov.in/
9. Ministry of Foreign Affairs of Japan, “1st Japan-India AI Strategic Dialogue,” April 2026. https://www.mofa.go.jp/press/release/pressite_000001_02290.html
10. India Brand Equity Foundation (IBEF), “India and Japan Hold First AI Strategic Dialogue in Mumbai to Strengthen Technology Cooperation,” April 2026. https://www.ibef.org/news/india-and-japan-hold-first-ai-strategic-dialogue-in-mumbai-to-strengthen-technology-cooperation
11. Government of India, Prime Minister’s Office, “Fact Sheet: India-Japan Economic Security Cooperation,” August 2025. https://www.pmindia.gov.in/en/news_updates/fact-sheet-india-japan-economic-security-cooperation/
12. International Bar Association, “Japan’s Evolving AI and Digital Health Regulations: Legal Developments and Outlook,” December 2025. https://www.ibanet.org/japan-ai-digital-health-regulations
13. BioSpectrum Asia, “Japan’s Strategic MedTech Alignment with India,” 2025. https://www.biospectrumasia.com/analysis/27/26283/japans-strategic-medtech-alignment-with-india.html
14. CSEP (Centre for Social and Economic Progress), “Indo–Japanese Collaboration on Artificial Intelligence,” January 2026. https://csep.org/policy-brief/indo-japanese-collaboration-on-artificial-intelligence/
15. Chambers and Partners, “Digital Healthcare 2025 – Japan: Trends and Developments,” June 2025. https://practiceguides.chambers.com/practice-guides/digital-healthcare-2025/japan/trends-and-developments
16. Asian Development Bank, “Artificial Intelligence: Applications in Healthcare (ADBI/JICA Workshop),” August 2025. https://www.adb.org/news/events/artificial-intelligence-applications-in-healthcare
17. Government of India, Press Information Bureau, “Fair, Secure and Efficient AI-driven Solutions in Health Sectors Solidifies India’s Position as a Pioneer in the Responsible Application of AI in Healthcare,” September 2025. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2163813
18. PMC/NIH, “Population Aging in Japan: Policy Transformation, Sustainable Development Goals, Universal Health Coverage, and Social Determinants of Health,” 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7731274/
19. Embassy of India, Tokyo, “India-Japan Bilateral Relations Overview,” Updated April 2026. https://www.indembassy-tokyo.gov.in/eoityo_pages/MTE
20. IMPRI (Impact and Policy Research Institute), “Indo-Japan Partnership for Semiconductors: An Assessment of Mutual Objectives and Supply Chain Autonomy,” October 2025. https://www.impriindia.com/insights/semiconductor-partnership-indo-japan/
21. PMC/NIH, “Governing Data and Artificial Intelligence for Health Care: Developing an International Understanding,” 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC8844981/
22. ARISE (ARO Alliance in ASEAN and East Asia), https://arise.jihs.go.jp/en/

By Arijita Banerjee. Senior Research Analyst, and Eratha Poongkuntran, Associate Director, Avasant